参考文献/References:
[1] Alves G, Forsaa EB, Pedersen KF, et al. Epidemiology of
Parkinson's disease [J]. J Neurol, 2008, 255(Suppl 5): 18-
32.
[2] Fahn S. The spectrum of levodopa-induced dyskinesias [J].
Ann Neurol, 2000，47(1): 2-11.
[3] Goyal AK, Khatri K, Vyas SP. Patents on Non-viral me-
diated gene delivery [J]. Recent Pat DNA Gene Seq, 2008, 2
(1): 44-60.
[4] 周 政，阴金波，杨 辉，等. TH 基因修饰的神经干细胞
移植治疗帕金森病的实验研究 [J].中华神经外科杂志，
2003，19（5）：375-379.
[5] Shen Y, Muramatsu S, Ikeguchi K, et al. Triple transduction
with adeno-associated virus vectors expressing tyrosine
hydroxylase, aromatic-L-amino-acid decarboxylase, and
GTP cyclohydrolase I for gene therapy of Parkinson's
disease [J]. Hum Gene Ther, 2000，11(11): 1509-1519.
[6] Muramatsu S, Fujimoto K, Kato S, et al. A phase I study of
aromatic L-amino acid decarboxylase gene therapy for
Parkinson's disease [J]. Mol Ther, 2010, 18(9): 1731-1735.
[7] Kirik D, Rosenblad C, Bjorklund A, et al. Long-term rAAV-
mediated gene transfer of GDNF in the rat Parkinson's
model: intrastriatal but not intranigral transduction promotes
functional regeneration in the lesioned nigrostriatal system
[J]. J Neurosci, 2000, 20(12): 4686-4700.
[8] Kordower JH, Emborg ME, Bloch J, et al. Neurodegeneration
prevented by lentiviral vector delivery of GDNF in primate
models of Parkinson's disease [J]. Science, 2000, 290(5492):
767-773.
[9] Coune PG, Schneider BL, Aebischer P, et al. Parkinson's
disease: gene therapies [J]. Cold Spring Harb Perspect Med,
2012，2(4): a009431.
[10] Kaoru S, Beate W, Christian TC, et al. A Nurr1/CoREST
transrepression pathway attenuates neurotoxic inflammation
in activated microglia and astrocytes [J]. Cell, 2009，137(1):
47-59.
[11] Nolan YM, Sullivan AM, Toulouse A, et al. Parkinson's
disease in the nuclear age of neuroinflammation [J]. Trends
Mol Med, 2013, 19(3): 187-196.
[12] Gasmi M, Herzog CD, Brandon EP, et al. Striatal delivery of
neurturin by CERE-120, an AAV2 vector for the treatment
of dopaminergic neuron degeneration in Parkinson's disease
[J]. Mol Ther, 2007，15(1): 62-68.
[13] Marks WJJ, Ostrem JL, Verhagen L, et al. Safety and tole-
rability of intraputaminal delivery of CERE-120 (adeno-
associated virus serotype 2-neurturin) to patients with idio-
pathic Parkinson's disease: an open-label, phase I trial [J].
Lancet Neurol, 2008，7(5): 400-408.
[14] Travis BL and David GS. Parkinson disease, primates, and
gene therapy: vive la différence [J]. Mov Disord, 2011, 26
(1): 2-3.
[15] Choi PS, Zakhary L, Choi WY, et al. Members of the
miRNA-200 family regulate olfactory neurogenesis [J].
Neuron, 2008, 57(1): 41-55.
[16] Junn E，Lee KW，Jeong BS, et al. Repression of alpha-
synuclein expression and toxicity by microRNA-7 [J]. Proc
Natl Acad Sci U S A, 2009，106(31): 13052-13057.
[17] McCormack AL, Mak SK, Henderson JM, et al. Alpha-
synuclein suppression by targeted small interfering RNA in
the primate substantia nigra [J]. PloS One, 2010, 5(8):
e12122
[18] Lim ST, Airavaara M, Harvey BK. Viral vectors for neuro-
trophic factor delivery: a gene therapy approach for neuro-
degenerative diseases of the CNS [J]. Pharmacol Res, 2010,
61(1): 14-26.
相似文献/References:
[1]张 威 李 楠 张海红 马 磊 高金鉴 王学廉 高国栋.丘脑底核与苍白球内侧部电刺激术治疗帕金森病疗效的Meta分析[J].中国临床神经外科杂志,2015,(12):718.[doi:10.13798/j.issn.1009-153X.2015.12.005]
ZHANG Wei,LI Nan,ZHANG Hai-hong,et al.Meta-analysis of curative effects of electric stimulation of the globus pallidus and subthalamic nucleus on Parkinson disease[J].,2015,(03):718.[doi:10.13798/j.issn.1009-153X.2015.12.005]
[2]管得宁,张 扬,徐 运.帕金森病的发病机制及治疗研究进展[J].中国临床神经外科杂志,2016,(11):732.[doi:10.13798/j.issn.1009-153X.2016.11.031]
[3]陈礼道 柳 雯 张 捷 付 锴 张继波 刘学猛 彭启珍 丁 伟.脂质头皮标志物在脑深部电刺激术针道设计中的应用[J].中国临床神经外科杂志,2017,(09):619.[doi:10.13798/j.issn.1009-153X.2017.09.004]
CHEN Li-dao,LIU Wen,ZHANG Jie,et al.Application of lipid scalp markers to the design of electrode track for deep brain stimulation in patients with movement disorders[J].,2017,(03):619.[doi:10.13798/j.issn.1009-153X.2017.09.004]
[4]陈宇昆 综述 王学廉 审校.脑深部电刺激术治疗帕金森病新进展[J].中国临床神经外科杂志,2018,(01):56.[doi:10.13798/j.issn.1009-153X.2018.01.024]
[5]陈礼道 综述 张 捷 审校.帕金森病脑深部电刺激术后程控策略[J].中国临床神经外科杂志,2018,(07):506.[doi:10.13798/j.issn.1009-153X.2018.07.021]
[6]姜 磊 邵 华 王西宪 石 鑫 冯兆海 郝玉军.丘脑底核电刺激术治疗帕金森病的疗效观察[J].中国临床神经外科杂志,2019,(01):13.[doi:10.13798/j.issn.1009-153X.2019.01.003]
JIANG Lei,SHAO Hua,WANG Xi-xian,et al.Curative effect of deep brain stimulation of subthalamic nucleus on Parkinson’s disease[J].,2019,(03):13.[doi:10.13798/j.issn.1009-153X.2019.01.003]
[7]张建英 马立山.DBS对帕金森病病人精神症状及认知功能的影响[J].中国临床神经外科杂志,2020,(10):703.[doi:10.13798/j.issn.1009-153X.2020.10.014]
[8]郭 松 任志伟 胡永生等.单纯影像定位与微电极辅助定位在帕金森病手术中的应用[J].中国临床神经外科杂志,2021,26(03):149.[doi:10.13798/j.issn.1009-153X.2021.03.002]
GUO Song,REN Zhi-wei,HU Yong-sheng,et al.Simple imaging-guided versus microelectrode recording-guided deep brain stimulaton for patients with Parkinson’s disease[J].,2021,26(03):149.[doi:10.13798/j.issn.1009-153X.2021.03.002]
[9]蒋 伟 郐国虎 刘魏华等.双侧丘脑底核脑深部电刺激术治疗帕金森病的疗效分析[J].中国临床神经外科杂志,2021,26(10):755.[doi:10.13798/j.issn.1009-153X.2021.10.004]
JIANG Wei,KUAI Guo-hu,LIU Wei-hua,et al.Clinical efficacy of bilateral subthalamic nucleus deep brain stimulation for patients with Parkinson’s disease[J].,2021,26(03):755.[doi:10.13798/j.issn.1009-153X.2021.10.004]
[10]杨 鑫 邵钰阳 聂 盼等.脑深部电刺激术治疗毁损术后帕金森病的疗效[J].中国临床神经外科杂志,2021,26(12):904.[doi:10.13798/j.issn.1009-153X.2021.12.003]
YANG Xin,SHAO Yu-yang,NIE Pan,et al.Efficacy of deep brain stimulation for patients with Parkinson’s disease after lesion surgery[J].,2021,26(03):904.[doi:10.13798/j.issn.1009-153X.2021.12.003]